Iqvia Rds France
- Address
- 17 Place Des Reflets
Sponsor Overview
Specializations
Neurocognitive Safety
Research activity is centred on the long-term effects of repeated exposure to gadolinium-based contrast agents in neurologically normal adults, with attention to changes in motor function and cognitive function over time.
- Motor performance
- Cognitive outcomes
- Long-term neurologic monitoring
The trial landscape includes comparison with a matched non-exposed control population to evaluate functional changes associated with repeated contrast-enhanced imaging.
Radiology and Contrast Imaging
The sponsor’s clinical interest includes contrast-enhanced MRI and the safety profile of repeated use of linear and macrocyclic gadolinium agents in imaging practice.
- Magnetic resonance imaging
- Contrast agent exposure
- Gadolinium retention concerns
Its funded research is aligned with evaluating whether repeated imaging-related exposure is associated with measurable functional effects in adults.
Adult Neurology
Current activity focuses on adult participants without known neurologic disease, with interest in subtle changes affecting neurologic function, coordination, and everyday cognition.
- Neurologically normal adults
- Functional neurologic assessment
- Age-related cognitive tracking
This places emphasis on detecting small but clinically relevant shifts in neurologic performance associated with repeated diagnostic exposure.
Multinational Clinical Research
The sponsor supports a multicountry research setting with collaborating sites across Europe, reflecting interest in coordinated clinical evaluation across diverse populations.
- Cross-border site collaboration
- Participant follow-up
- Comparative observational analysis
Site participation extends the assessment of imaging-related safety outcomes across several active trial locations.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of Long-term Effects of Repeated Gadolinium-based Contrast Agents on Motor and Cognitive Functions in Neurologically Normal Adults |  France Germany Italy | Not Yet Recruiting |
Data & Insights
This sponsor works with 5 molecules, of which 2 are not being studied by other sponsors.
This sponsor has worked with 15 sites across their trial portfolio.
Therapeutic Focus
- 1.Diagnosis1 trial83 other sponsors
Partnered Research Centres
15 centres- Address
- Via Nicolo' Giustiniani 2, 35128 Padua
- Address
- Strada Delle Scotte 14, 53100 Siena
- Address
- Strada Di Fiume 447, 34149 Trieste
- Address
- Via Giovanni Amendola 2, 42122 Reggio Emilia
- Address
- Theodor-Stern-Kai 7, 60590 Frankfurt
- Address
- 1 Place De L Hopital, Cs 80426, 67091 STRASBOURG, Alsace
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Iqvia Rds France.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.